Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Shoba Ravichandran"'
Autor:
Mônica R Gadelha, Feng Gu, Marcello D Bronstein, Thierry C Brue, Maria Fleseriu, Ilan Shimon, Aart J van der Lely, Shoba Ravichandran, Albert Kandra, Alberto M Pedroncelli, Annamaria A L Colao
Publikováno v:
Endocrine Connections, Vol 9, Iss 12, Pp 1178-1190 (2020)
Pasireotide, a multireceptor-targeted somatostatin analog with highest affinity for somatostatin receptor subtype (SST) 5, has demonstrated superio r efficacy over the SST2-preferential somatostatin analogs octreotide and lanreotide. The safety profi
Externí odkaz:
https://doaj.org/article/45729ec454b4435ba63f2c136e79dce5
Autor:
Alexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Falk G Bechara, Carle Paul, Evangelos J Giamarellos Bourboulis, Axel P Villani, Andreas Schwinn, Franziska Ruëff, Larisha Pillay Ramaya, Adam Reich, Ines Lobo, Rodney Sinclair, Thierry Passeron, Antonio Martorell, Pedro Mendes-Bastos, Georgios Kokolakis, Pierre-Andre Becherel, Magdalena B Wozniak, Angela Llobet Martinez, Xiaoling Wei, Lorenz Uhlmann, Anna Passera, Deborah Keefe, Ruvie Martin, Clarice Field, Li Chen, Marc Vandemeulebroecke, Shoba Ravichandran, Elisa Muscianisi
Publikováno v:
The Lancet. 401:747-761
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eff0f5b3f079585021cebd8eccc46ca1
https://doi.org/10.1016/s0140-6736(23)00022-3
https://doi.org/10.1016/s0140-6736(23)00022-3
Autor:
Nicholas J. Vogelzang, Austin Poole, Wei Gao, Xiting Cao, Lixian Jin, Derek H. Tang, Barbara Ratto, Elyse Swallow, Shoba Ravichandran
Publikováno v:
Clinical Genitourinary Cancer. 18:e37-e45
Introduction In the first-line (1L) setting, pazopanib (PAZ) has been recommended by the National Comprehensive Cancer Network for the treatment of advanced renal cell carcinoma (aRCC). In 2018, immuno-oncology (IO) therapy became a commonly used 1L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684c89957b90d9bb5099a12d3b9bf676
https://doi.org/10.1016/j.clgc.2019.10.010
https://doi.org/10.1016/j.clgc.2019.10.010
Autor:
Vincent Chung, Raymond P. Perez, Martin Gutierrez, Ravi K. Amaravadi, Mark Allen O’Rourke, John Sarantopoulos, Nicholas Squittieri, Darcy B. Pooler, James J. Lee, Ulka N. Vaishampayan, Lionel D. Lewis, Shoba Ravichandran, Carolyn D. Britten, Anthony J. Olszanski, Dylan B. Ness, Patricia LoRusso, Geoffrey I. Shapiro
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 87(3)
AIMS We evaluated the potential effect of sonidegib at an oral dose of 800 mg once daily (QD) on the pharmacokinetics (PK) of the probe drugs warfarin (CYP2C9) and bupropion (CYP2B6). METHODS This was a multicentre, open-label study to evaluate the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7434d417440e734a8cf1a64e1ecce5a7
https://pubmed.ncbi.nlm.nih.gov/32736411
https://pubmed.ncbi.nlm.nih.gov/32736411
Autor:
Ariel L. Barkan, Marcello D. Bronstein, T. Delibasi, S. Petersenn, Shoba Ravichandran, Rosario Pivonello, Roberto Salvatori, Jochen Schopohl, N. Suzaki, André Lacroix, C.-E. Ortmann, Libuse Tauchmanova, Yixue Li
Purpose: Cushing’s disease (CD) is associated with significant clinical burden, increased mortality risk, and impaired health-related quality of life (HRQoL). This analysis explored the effect of long-acting pasireotide on clinical signs of hyperco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7695c3b0778a578e1abacbc35b9c1bda
http://hdl.handle.net/11588/823824
http://hdl.handle.net/11588/823824
Autor:
John Newell-Price, Maria Fleseriu, Mônica R. Gadelha, Antoine Tabarin, André Lacroix, Libuse Tauchmanova, Beverly M. K. Biller, Przemysław Witek, Stephan Petersenn, Rosario Pivonello, Pritam Gupta, Shoba Ravichandran
Publikováno v:
European Journal of Endocrinology
Objective Monitoring of patients with Cushing’s disease on cortisol-lowering drugs is usually performed with urinary free cortisol (UFC). Late-night salivary cortisol (LNSC) has an established role in screening for hypercortisolism and can help to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500c74fa29c6acb7890a574208c3edb9
https://pubmed.ncbi.nlm.nih.gov/31804965
https://pubmed.ncbi.nlm.nih.gov/31804965
Autor:
Libuse Tauchmanovà, Pinar Kadioglu, Maria Fleseriu, Guy T'Sjoen, Marie C Vantyghem, John Newell-Price, S. Petersenn, Beverly M. K. Biller, Block Christophe De, André Lacroix, Shoba Ravichandran, Michael Roughton
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::badd8c06d559b9d2c6251cc561b5c741
https://doi.org/10.1530/endoabs.56.gp204
https://doi.org/10.1530/endoabs.56.gp204
Autor:
Libuse Tauchmanovà, Beverly M. K. Biller, Przemysław Witek, André Lacroix, S. Petersenn, Eliza B Geer, Michael Roughton, Yiming Li, Shoba Ravichandran, Richard A Feelders, Thierry Brue
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b999ee42dd3380a3c9b99f99ce04e6fe
https://doi.org/10.1530/endoabs.56.gp205
https://doi.org/10.1530/endoabs.56.gp205
Autor:
Maria Fleseriu, Akira Shimatsu, Antoine Tabarin, Shozo Yamada, Christophe De Block, Atsuhiro Ichihara, Tuncay Delibasi, Stephan Petersenn, Carmen Fajardo-Montañana, Francesco Cavagnini, Yerong Yu, Ariel L. Barkan, Richard A Feelders, Thiti Snabboon, Roberto Salvatori, Przemysław Witek, Dario Bruera, Peter J. Snyder, Adriana G. Ioachimescu, Christof Schöfl, Mônica R. Gadelha, Marek Bolanowski, Abdurrahman Comlekci, Tushar Bandgar, Giorgio Arnaldi, Paola Loli, Syed Ali Imran, Eliza B Geer, Shoba Ravichandran, Marie-Christine Vantyghem, Michael Roughton, Hesarghatta Shyamasunder Asha, Feng Gu, Anthony P. Heaney, Guy T'Sjoen, Henrik Biering, Marcello D. Bronstein, Beverly M. K. Biller, Susana Tara Britto, Wilson Gallardo, Marie Bex, Liudmila Rozhinskaya, Youichi Saitoh, Brigitte Velkeniers, John Newell-Price, Pinar Kadioglu, André Lacroix, Ghislaine Houde, Masanobu Yamada, Jochen Schopohl, Mitsuru Nishiyama, Libuse Tauchmanova, Thierry Brue, Yiming Li, Susan M. Webb, Marco Boscaro, Chikara Shimizu, Rosario Pivonello, Marek Ruchała, Yutaka Takahashi, Noriyuki Suzaki
BACKGROUND: Cushing's disease is a rare debilitating endocrine disorder for which few prospective interventional studies have been done. We report results of the first phase 3 trial assessing long-acting intramuscular pasireotide in patients with Cus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138b0c53f24ef44ccb2a8d46d1eedd27
http://hdl.handle.net/11588/703618
http://hdl.handle.net/11588/703618
Autor:
Madan G. Kundu, Jennifer A. Chan, Ke Hu, James C. Yao, Karina Hermosillo Reséndiz, Edward M. Wolin, Shoba Ravichandran, Alain C. Mita, Jonathan R. Strosberg
Publikováno v:
OncoTargets and therapy
James C Yao,1 Jennifer A Chan,2 Alain C Mita,3 Madan G Kundu,4 Karina Hermosillo Reséndiz,4 Ke Hu,4 Shoba Ravichandran,4 Jonathan R Strosberg,5 Edward M Wolin6 1GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2Ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6639530670802be58f10ad66cdc1d8f3
https://pubmed.ncbi.nlm.nih.gov/28721067
https://pubmed.ncbi.nlm.nih.gov/28721067